Generic Drug Acceptance: A Study from Selected State Community Pharmacies in Peradeniya and Jaffna

Show simple item record

dc.contributor.author Kuganesan, N.
dc.contributor.author De Silva, K.I.M.
dc.contributor.author Sakeena, M.H.F.
dc.date.accessioned 2025-10-29T05:46:15Z
dc.date.available 2025-10-29T05:46:15Z
dc.date.issued 2025-08-07
dc.identifier.citation Kuganesan, N., De Silva, K.I.M., Sakeena, M.H.F. (2025). Generic Drug Acceptance: A Study from Selected State Community Pharmacies in Peradeniya and Jaffna. Proceedings of 3rd International Research Symposium of the Faculty of Allied Health Sciences University of Ruhuna, Galle, Sri Lanka, 3. 02. en_US
dc.identifier.issn 2659-2029
dc.identifier.uri http://ir.lib.ruh.ac.lk/handle/iruor/20337
dc.description.abstract Background: Generic drugs are cost-effective, bioequivalent alternatives to brand-name medications, and are comparable in quality, efficacy, and safety. Despite their benefits, uptake is hindered by negative patient perceptions and limited awareness. In Sri Lanka, where healthcare affordability is a major concern, increasing generic use could significantly reduce healthcare costs. Thus, evaluating patient perception and acceptance is crucial. Objectives: To assess patients' perceptions and acceptance of generic drugs in selected state community pharmacies in Peradeniya and Jaffna and to identify factors influencing acceptance Methods: A descriptive, cross-sectional survey was conducted between August and October 2024 at two state-owned pharmacies (Rajya Osusala) in Peradeniya and Jaffna. Patients obtaining prescription medications were recruited using convenience sampling. Data were collected using a validated, interviewer-administered questionnaire, adapted from a previously published study. The questionnaire underwent expert validation and pre-testing to suit the local context and study objectives. Data were analysed using SPSS version 26.0. Results: Of the 390 participants, 67.9% (n=265) reported using generic drugs, and 61.3% (n=239) expressed confidence in their efficacy. Affordability was the primary reason for preferring generics (41.8%, n=163). However, concerns regarding quality (23.8%, n=93), effectiveness (23.1%, n=90), and side effects (16.7%, n=65) remained. Only 43.1% were willing to use generics for serious or life-threatening conditions. Individuals with higher education reported greater use of generic drugs (p=0.017), whereas preferences for branded drugs and perceptions of efficacy, quality and side effects showed no significant associations (p>0.05). Physician recommendation strongly influenced decisions: 58.7% (n=229) preferred confirmation from a doctor before switching to a generic, compared to 41.0% (n=160) who would switch based on a pharmacist’s recommendation. Conclusions: Generic drug acceptance was relatively high among patients. Educational level and physician endorsement significantly influenced acceptance. Enhanced awareness and healthcare provider-led interventions are recommended to improve generic drug acceptance en_US
dc.language.iso en en_US
dc.publisher FAHS en_US
dc.relation.ispartofseries ;OP 01
dc.subject Acceptance en_US
dc.subject Generic drugs en_US
dc.subject Healthcare cost en_US
dc.subject Patient perception en_US
dc.title Generic Drug Acceptance: A Study from Selected State Community Pharmacies in Peradeniya and Jaffna en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account